ClinicalTrials.Veeva

Menu

Effect of Endometrial Thickness on IVF Outcome

Z

Zhengzhou University

Status

Unknown

Conditions

Infertility

Treatments

Procedure: Embryo transfer

Study type

Observational

Funder types

Other

Identifiers

NCT02420704
RMCZZU-Endometrial thickness

Details and patient eligibility

About

Although many studies have evaluated the relationship between endometrial thickness and IVF outcome, the results are still controversial. We notice that, during our daily work, for patients undergoing cleavage stage embryo transfer, endometrial thickness seems to have a huge impact on IVF outcome; however, for blastocyst stage embryo transfers, IVF outcome seems to have little association with endometrial thickness. Thus, the aim of this prospective observational study is to explore the relationship between endometrial thickness and IVF outcome in patients undergoing cleavage stage and blastocyst stage embryo transfers, respectively.

Enrollment

500 estimated patients

Sex

Female

Ages

22 to 38 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age between 22-38 years old;
  • the first cycle of IVF treatment with standard long protocol;
  • transfrred with at least two high quality cleavage stage embryos, or with at least one high quality blastocyst stage embryo.

Exclusion criteria

  • PGD cycles;
  • gamete donation cycles

Trial design

500 participants in 6 patient groups

Cleavage stage-thin endometrial
Description:
Patients transferred with cleavage stage embryo, with endometrial thickness ≤7mm on the day of HCG (human chorionic gonadotropin) administration for fresh cycles, or on the day starting to use progesterone for frozen thawed cycles.
Treatment:
Procedure: Embryo transfer
Cleavage stage-medium endometrial
Description:
Patients transferred with cleavage stage embryo, with endometrial thickness 8-13mm on the day of HCG (human chorionic gonadotropin) administration for fresh cycles, or on the day starting to use progesterone for frozen thawed cycles.
Treatment:
Procedure: Embryo transfer
Cleavage stage-thick endometrial
Description:
Patients transferred with cleavage stage embryo, with endometrial thickness ≥14mm on the day of HCG (human chorionic gonadotropin) administration for fresh cycles, or on the day starting to use progesterone for frozen thawed cycles.
Treatment:
Procedure: Embryo transfer
Blastocyst stage-thin endometrial
Description:
Patients transferred with blastocyst stage embryo, with endometrial thickness ≤7mm on the day of HCG (human chorionic gonadotropin) administration for fresh cycles, or on the day starting to use progesterone for frozen thawed cycles.
Treatment:
Procedure: Embryo transfer
Blastocyst stage-medium endometrial
Description:
Patients transferred with blastocyst stage embryo, with endometrial thickness 8-13mm on the day of HCG (human chorionic gonadotropin) administration for fresh cycles, or on the day starting to use progesterone for frozen thawed cycles.
Treatment:
Procedure: Embryo transfer
Blastocyst stage-thick endometrial
Description:
Patients transferred with blastocyst stage embryo, with endometrial thickness ≥14mm on the day of HCG (human chorionic gonadotropin) administration for fresh cycles, or on the day starting to use progesterone for frozen thawed cycles.
Treatment:
Procedure: Embryo transfer

Trial contacts and locations

1

Loading...

Central trial contact

Zhiqin Bu, M.D; Yingpu Sun, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems